Last update 14 Nov 2025

Antisense oligonucleotide(Praxis Precision Medicines/ReCode Therapeutics)

Overview

Basic Info

Drug Type
ASO
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesUrogenital DiseasesOther Diseases
Active Indication
Chronic Kidney DiseasesSarcopeniaCentral Nervous System Diseases
Inactive Indication-
Originator Organization
ReCode Therapeutics, Inc.ReCode Therapeutics, Inc.
Praxis Precision Medicines, Inc.Praxis Precision Medicines, Inc.
Active Organization
Praxis Precision Medicines, Inc.Praxis Precision Medicines, Inc.Shimane UniversityShimane UniversityReCode Therapeutics, Inc.ReCode Therapeutics, Inc.
Inactive Organization-
License Organization
ReCode Therapeutics, Inc.ReCode Therapeutics, Inc.
Praxis Precision Medicines, Inc.Praxis Precision Medicines, Inc.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

100 Clinical Results associated with Antisense oligonucleotide(Praxis Precision Medicines/ReCode Therapeutics)
Login to view more data
100 Translational Medicine associated with Antisense oligonucleotide(Praxis Precision Medicines/ReCode Therapeutics)
Login to view more data
100 Patents (Medical) associated with Antisense oligonucleotide(Praxis Precision Medicines/ReCode Therapeutics)
Login to view more data
100 Deals associated with Antisense oligonucleotide(Praxis Precision Medicines/ReCode Therapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPreclinical
Japan
Shimane UniversityShimane University
27 Mar 2025
SarcopeniaPreclinical
Japan
Shimane UniversityShimane University
27 Mar 2025
Central Nervous System DiseasesDiscovery
United States
Praxis Precision Medicines, Inc.Praxis Precision Medicines, Inc.
29 Sep 2025
Central Nervous System DiseasesDiscovery
United States
ReCode Therapeutics, Inc.ReCode Therapeutics, Inc.
29 Sep 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free